The Safety and Efficacy of
Viramidine Plus PegIFN
alfa-2b Versus Ribavirin
Plus PegIFN alfa-2b in
Therapy-Naïve Patients
Infected with HCV: Phase 3
Results (VISER1)
Y Benhamou and others.
Abstract |
Descargar archivo |
|
Sustained Virologic Response
(SVR) to Interferon alfa-2b
+/- Ribavirin Therapy at 6
Months Reliably Predicts
Long-term Clearance of HCV
at 5-Year Follow Up
J McHutchison and others.
Abstract 744. |
Descargar archivo |
|
Treatment Comparison of
Patients with Chronic
Hepatitis C and Elevated ALT
vs Patients with
Persistently Normal ALT:
Preliminary Results of a
Prospective Open Trial
W Vogel others. Abstract
615. |
Descargar archivo |
|
Peginterferon alfa-2b
Therapy with and without
Ribavirin in Patients with
Thalassemia: A Randomized
Study
S Kamal and others. Abstract
585. |
Descargar archivo |
|
Long-term, Low-dose
Treatment with Pegylated
Interferon alfa 2b Leads to
a Significant Reduction in
Fibrosis and Inflammatory
Score in Chronic Hepatitis C
Nonresponder Patients with
Fibrosis or Cirrhosis
S Kaiser and others.
Abstract 584. |
Descargar archivo |
|
Early Detection of
Depressive Symptoms During
Treatment With Pegylated
Interferon a-2b and
Ribavirin in Euthymic
Chronic Hepatitis C Patients
P Goldstein and others.
Abstract 5776. |
Descargar archivo |
|
More Rapid Drop of HCV RNA
Level under Therapy and
Better Sustained Response
Rate in Egyptian Patients
versus Non-Egyptian Patients
with HCV Genotype 4
A El Ray and others.
Abstract 571. |
Descargar archivo |
|
|
HEPATITIS B |
|
|
Final Analysis of
Virological Outcomes and
Resistance During 5 Years of
Adefovir Dipivoxil
Monotherapy in HBeAg-Negative
Patients
K Borroto-Esoda and others.
Abstract 483. |
Descargar archivo |
|
Safety and Efficacy of
Adefovir Dipivoxil in
Patients with Lamivudine-
Resistant Chronic Hepatitis
B Undergoing Liver
Transplantation
E Schiff and others.
Abstract 2. |
Descargar archivo |
|
Two-State Modeling of
Virological and Biochemical
Efficacy Plus Liver Biopsies
Demonstrate Effi cacy of
Adefovir Dipivoxil in HBeAg-Negative
Chronic Hepatitis B over 4
or 5 Years
S Hadziyannis and others.
Abstract 494. |
Descargar archivo |
|
The Improved Therapeutic
Effects of Adefovir
Dipivoxil in Patients with
HBeAg-Negative Chronic
Hepatitis B Offset Its
Increased Cost Compared to
Lamivudine
M Buti and others. Abstract
485. |
Descargar archivo |
|
Durability of HBeAg
Seroconversion Following
Adefovir Dipivoxil Treatment
for Chronic Hepatitis B
TT Chang and others.
Abstract 503. |
Descargar archivo |
|
|
HIV-HCV
Coinfection |
|
|
Effect of Peginterferon
alfa-2b and Ribavirin on
Histological Lesions in
Patients with Hepatitis C
Virus (HCV) and HCV/HIV Co-Infection:
An Open-Label Trial |
Descargar archivo
|
|
|
